HALP as a Novel Score for Prediction of Mortality and re_bleeding in Upper GIT Bleeding

ConditionUpper Gastrointestinal Bleeding

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorSohag University

About this trial

Evaluation of the prognostic utility of the HALP score in patients with upper gastrointestinal bleeding, particularly in predicting re\_bleeding risk and mortality in internal medicine department in Sohag University Hospitals.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients will be included if they were initially admitted to the emergency department, had a confirmed diagnosis of upper gastrointestinal bleeding via endoscopy, and were 18 years of age or older.

Disqualifiers

Incomplete clinical data.

Lack of laboratory results obtained at emergency department admission necessary for the calculation of HALP score; albumin, hemoglobin (HGB), platelets (PLT), or international normalized ratio (INR).

Pregnancy

Patients with missing data on clinical outcomes

Trial population

Patients with upper gastrointestinal bleeding

Trial design

Design model

Case-only

Time perspective

Prospective

Treatments tested in this trial

Upper endoscopy
Diagnostic test
Prediction of upper gastrointestinal r\_bleeding and mortality

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

"Mortality"

Time frame

6 months

Incidence of "Re_bleeding"

Time frame

6 months

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Sohag University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: